Core Points - The company aims to strengthen budget management, enhance internal controls, prevent operational risks, and improve management levels and economic efficiency through the implementation of a comprehensive budget system [1][2]. Group 1: Comprehensive Budget Management - Comprehensive budgeting involves overall forecasts of business activities and financial conditions over a specific period, typically one year, including business, investment, financing, and financial budgets [1][2]. - The comprehensive budget management system applies to the company headquarters, all levels of subsidiaries, and other entities included in the consolidated financial statements [1]. - The basic principles of comprehensive budget management include strategic alignment, resource optimization, comprehensiveness, and rigidity [1][2]. Group 2: Budget Management Structure - The budget management structure consists of a budget management committee, budget management office, budget management departments, and various budget execution entities [2][5]. - The budget management committee is responsible for reviewing the overall goals, policies, and annual budgets of the company [4][5]. - The budget management office handles daily management tasks and initial reviews of annual budget drafts from various execution entities [2][3]. Group 3: Budget Execution and Control - Once approved, the comprehensive budget must be implemented diligently, with budget indicators broken down to all departments and positions to ensure the achievement of budget goals [12]. - Budget execution analysis reports are required to track and analyze the execution progress and variances, which are then reported up the hierarchy [25][26]. - The company will establish a budget monitoring meeting system to address issues arising during budget execution [26][27]. Group 4: Budget Adjustment - The company generally does not adjust budgets once approved, except in cases of significant changes in market conditions or other objective factors that lead to substantial deviations [29][30]. - Budget adjustments must adhere to principles such as responsibility assignment, goal consistency, and efficiency [30][31]. Group 5: Budget Assessment and Incentives - Budget assessment serves as a comprehensive evaluation of the operational performance of various units and the effectiveness of budget execution [33]. - The budget assessment process includes both ongoing quarterly evaluations and a comprehensive year-end assessment [35][36]. - The internal audit institution will incorporate budget execution audits into its annual audit plan, with results serving as a basis for budget adjustments and management improvements [36][37].

第七条 本制度所指内幕信息是指根据《证券法》的相关规定，涉及公司的经营、 财务或者对公司证券市场价格有重大影响的尚未公开的信息，以及《证券法》第八 十条第二款、第八十一条第二款所列重大事件。尚未公开是指公司尚未在上海证券 交易所的网站和符合国务院证券监督管理机构规定条件的媒体公开披露。 第二章 内幕信息及内幕人员的范围 第三条 公司董事会应当按照本制度以及上海证券交易所相关规则要求及时登 记和报送内幕信息知情人档案，并保证内幕信息知情人档案真实、准确和完整，公 司董事长为主要责任人。公司董事会秘书负责办理公司内幕信息知情人的登记入档 和报送事宜。董事长与董事会秘书应当对内幕信息知情人档案的真实、准确和完整 签署书面确认意见。公司董事会办公室协助董事会秘书进行公司内幕信息知情人登 记管理的日常工作，及时告知内幕信息知情人的各项保密义务，并依据各项法规制 度控制内幕信息的传递和知情范围。 第四条 董事会秘书和董事会办公室负责证券监管机构、证券交易所、证券公司 等机构及新闻媒体、股东的接待、咨询工作。 第五条 董事会办公室是公司唯一的信息披露机构。未经董事会批准同意，公司 任何部门和个人不得向外界泄露、报道、传送涉 ...

第一章 总则 《鲁商福瑞达医药股份 有限公司章程》（以下简称"公司章程"）等有关规定，制定本制度。 第二条 内部审计是指公司内部机构或人员，对公司内部控制和风险管理的 有效性、财务信息的真实性和完整性以及经营活动的效率和效果等开展的一种评 价活动。它通过系统、规范的方法，审查、评价公司各级组织经营活动及目标实 现、内部控制建立执行、资源利用等情况。 第三条 内部审计的目的是促进公司依法经营、规范管理、提高效益，增强 风险防控能力。 第一条 为加强鲁商福瑞达医药股份有限公司（以下简称"公司"）内部管 理和审计监督，维护公司合法权益，强化公司经营管理，促使公司经营活动持续 健康发展，根据《中华人民共和国公司法》 《上海证券交易所股票上市规则》 《审 计署关于内部审计工作的规定》 《企业内部控制基本规范》 第四条 本制度适用于公司及公司所有全资子公司和控股子公司（以下简称 "公司及子公司"）。 第二章 内部审计机构和职责 第五条 公司设立审计法务部，配备专职内部审计人员。 审计法务部是审计委员会监督指导下独立开展工作的内部审计机构，是审 计人员的日常办事机构，依照国家法规、政策和企业规章制度，独立行使内部审 计职权 ...

Core Points - The document establishes a long-term mechanism to prevent major shareholders and related parties from occupying company funds and regulates financial transactions between the company and related parties [1][2] - The board of directors and senior management are obligated to ensure the safety of company funds and regulate financial transactions with related parties [1][2] Group 1: General Provisions - The provisions apply to the company and its wholly-owned and controlling subsidiaries regarding financial transactions with related parties [2] - The definition of fund occupation includes both operational and non-operational fund occupation [1][2] Group 2: Measures to Regulate Related Fund Transactions - The board of directors must review and approve the transaction amounts between the company and related parties, and take effective measures to stop any fund occupation [2][3] - Strict adherence to contract terms is required for operational fund transactions to avoid fund occupation [2][3] - The company is prohibited from providing funds to related parties in various specified ways, including covering expenses or lending funds without proper transaction backgrounds [2][3][4] Group 3: Responsibilities and Accountability - The board of directors must take immediate action to recover occupied funds and interest in cases of non-operational fund occupation [3][4] - Borrowing amounts over 3 million yuan that exceed 0.5% of the latest audited net assets requires board approval and disclosure [3][4] - The chairman of the board is the primary responsible person for preventing fund occupation and managing recovery efforts [4][5] Group 4: Accountability and Penalties - Directors and senior management who assist or condone fund occupation may face disciplinary actions, including potential dismissal [6] - In cases of violations, the company can impose administrative and economic penalties and may pursue legal responsibility against relevant individuals [6]

第一章 总则 第一条 为完善公司法人治理结构，规范公司选举董事行为，维护中小股东利益， 依照《中华人民共和国公司法》《上市公司治理准则》《上海证券交易所股票上市规 则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等法律、法规和 规范性文件的规定，和《鲁商福瑞达医药股份有限公司章程》（以下简称"公司章程" 等有关规定，特制定本实施细则。 第二条 本实施细则所称累积投票制，是指股东会选举两名以上董事（含独立董 事），单一股东及其一致行动人拥有权益的股份比例在百分之三十及以上时，出席股 东会的股东（以下简称"出席股东"）所拥有的投票权数等于所持有的股份总数与该 次股东会应选董事人数之积，出席股东可以将其拥有的投票权数全部投向一位董事候 选人，也可以将其拥有的投票权数分散投向多位董事候选人，按得票多少依次决定董 事入选的表决制度。 本实施细则所称的董事不包括职工代表董事，职工代表董事由公司职工通过职工 （代表）大会或者其他形式民主选举产生或更换，不适用本实施细则的相关规定。 第三条 本实施细则适用于选举和更换两个或者两个以上的董事的议案。 第四条 在一次股东会上，拟选举两名或两名以上的董事时，董事会应 ...

Core Points - The document outlines the regulations and principles governing related party transactions for Lushang Furuida Pharmaceutical Co., Ltd, ensuring legality, fairness, and protection of shareholders' rights, especially for minority and non-related shareholders [1][2][3] Group 1: General Principles - The company aims to minimize related party transactions and ensure that transaction prices are fair, just, and publicly disclosed [2][3] - Related party transactions must not harm the legal rights of all shareholders, particularly minority and non-related shareholders [3] Group 2: Identification of Related Parties - Related parties include both legal entities and natural persons that have significant control or ownership over the company [4][5] - Specific criteria are established for identifying related legal entities and natural persons, including ownership thresholds and management positions [5][6] Group 3: Scope of Related Transactions - Related transactions encompass resource transfers or obligations between the company and its related parties, including various financial and operational activities [11][12] Group 4: Decision-Making Procedures and Disclosure - Transactions exceeding 30 million yuan or 5% of the company's net assets require disclosure and shareholder approval [12][13] - Daily related transactions may not require auditing unless specified by regulatory authorities or company bylaws [12][13] Group 5: Pricing and Management of Related Transactions - Pricing for related transactions should primarily follow market prices, with alternative methods like cost-plus pricing applicable when market prices are unavailable [26][27] Group 6: Exemptions from Disclosure and Approval - Certain transactions, such as those providing unilateral benefits without obligations, may be exempt from standard approval and disclosure requirements [30][31]

第一章 总 则 第一条 为提高鲁商福瑞达医药股份有限公司（以下简称"公司"）治理水 平，加强对董事会秘书工作的管理与监督，充分发挥董事会秘书的作用，根据《中 华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国证券法》、 $$\mathbb{C}$$ 海证券交易所股票上市规则》等有关法律、法规、规范性文件以及《鲁商福瑞达 医药股份有限公司公司章程》 （以下简称"公司章程"）的规定，结合公司实际情 况，制定本工作制度。 第二条 公司设董事会秘书一名，董事会秘书为公司高级管理人员，对公司 和董事会负责，应忠实、勤勉地履行职责。公司设立董事会办公室作为信息披露 事务部门，董事会办公室由董事会秘书负责管理。 第三条 公司董事会在聘请董事会秘书的同时，委任一名证券事务代表，协 助董事会秘书履行职责，在董事会秘书不能履行职责时，证券事务代表应当代为 履行职责。在此期间，并不当然免除董事会秘书对公司信息披露等事务所负有的 责任。证券事务代表应参照本工作制度履职。 第二章 任职资格 第四条 担任公司董事会秘书，应当具备以下条件： （一）具有良好的职业道德和个人品质； （二）具备履行职责所必需的财务、管理、法律 ...

第一章 总则 第一条 为了规范鲁商福瑞达医药股份有限公司（以下简称"公司"）的 对外担保行为，有效控制公司对外担保风险，维护广大股东的合法权益，根据 《中华人民共和国公司法》《中华人民共和国证券法》《中华人民共和国民法 典》 《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》和《上海证券交易所股票上市规则》等法律法规和规范性文件以及《鲁商 福瑞达医药股份有限公司章程》（以下简称"公司章程"）的有关规定，特制 定本制度。 第二条 本制度所称对外担保是指公司为他人提供的担保，包括保证、抵 押或质押等方式，包括公司对全资、控股子公司的担保。 第三条 公司全资子公司和控股子公司（以下合称"控股子公司"）的对 外担保，视同公司行为，其对外担保应执行本制度。 公司控股子公司为公司合并报表范围内的法人或者其他组织提供担保的， 应在其董事会或股东会做出决议后及时通知公司履行有关信息披露义务，按照 《上海证券交易所股票上市规则》应当提交公司股东会审议的担保事项除外。 公司控股子公司为公司合并报表范围以外的其他主体提供担保的，视同公 司提供担保，公司履行审议程序并披露。控股子公司应在履行其审议程序前按 照报 ...

第一章 总则 第一条 为规范鲁商福瑞达医药股份有限公司（以下简称"公司"）信息披 露行为，加强信息披露事务管理，保护投资者合法权益，根据《中华人民共和国 公司法》《中华人民共和国证券法》《上市公司信息披露管理办法》《上海证券 交易所股票上市规则》（以下简称"《上市规则》"）、《上海证券交易所上市 公司自律监管指引第 2 号——信息披露事务管理》等国家有关法律、法规、规范 性文件及《鲁商福瑞达医药股份有限公司章程》（以下简称"公司章程"）的有 关规定，制定本信息披露管理制度（以下简称"本制度"）。 第二条 本制度所称"信息"是指所有可能对公司证券及其衍生品种交易价 格以及投资者作出价值判断和投资决策产生重大影响的信息，以及证券监督管理 部门要求披露的信息；信息披露文件主要包括定期报告、临时报告、招股说明书、 募集说明书、上市公告书、收购报告书等。 第三条 本制度所称"披露"是指在法律法规和中国证券监督管理委员会（以 下简称"中国证监会"）及上海证券交易所规定的时间内，在上海证券交易所的 网站和符合中国证监会规定条件的媒体上，以规定的披露方式向社会公众公布前 述信息，并按规定报送证券监管部门。 信息披露义务人，是 ...

Core Viewpoint - The document outlines the regulations and responsibilities of independent directors at Lushang Furida Pharmaceutical Co., Ltd, emphasizing their role in corporate governance and the protection of minority shareholders' rights [2][3][4]. Group 1: Independent Director Definition and Responsibilities - Independent directors must not hold any other positions within the company and should have no direct or indirect interests that could affect their judgment [3][4]. - They are obligated to act in good faith and diligence towards the company and all shareholders, participating in decision-making, supervision, and providing professional advice [3][4][10]. - The proportion of independent directors on the board must not be less than one-third, including at least one accounting professional [4][5]. Group 2: Qualifications and Independence - Independent directors must meet specific qualifications, including relevant work experience and a clean personal record [5][6]. - Individuals with significant relationships or interests in the company or its major shareholders are prohibited from serving as independent directors [5][6][7]. Group 3: Nomination and Election Process - Shareholders holding more than 1% of the company's shares can propose independent director candidates, who must be approved by the shareholders' meeting [8][9]. - The company must disclose the qualifications and independence of the nominated candidates to the stock exchange [8][9]. Group 4: Duties and Rights - Independent directors have the right to independently hire external advisors for audits or consultations and can propose meetings to discuss significant issues [10][11]. - They must attend board meetings and provide clear opinions on agenda items, including dissenting opinions when necessary [10][12]. Group 5: Communication and Reporting - Independent directors should maintain communication with minority shareholders and report any issues that may affect their independence [12][13]. - They are required to submit annual reports to the shareholders' meeting, detailing their activities and any concerns [16][19]. Group 6: Support and Compensation - The company must provide necessary support and resources for independent directors to fulfill their duties effectively [33][34]. - Independent directors are entitled to compensation that reflects their responsibilities, which must be approved by the shareholders [39][40].